Revisiting metronomic vinorelbine with mathematical modelling: a Phase I trial in lung cancer

被引：0

作者：

Fabrice Barlesi

Laure Deyme

Diane-Charlotte Imbs

Elissa Cousin

Mathieu Barbolosi

Sylvanie Bonnet

Pascale Tomasini

Laurent Greillier

Melissa Galloux

Albane Testot-Ferry

Annick Pelletier

Nicolas André

Joseph Ciccolini

Dominique Barbolosi

机构：

[1] Aix Marseille University,Marseille Early Phases Cancer Trials Center CLIP

[2] APHM,SMARTc Unit Centre de Recherche en Cancérologie de Marseille Inserm U1068

[3] Aix Marseille University,Department of Pharmacology Marseille

[4] Gustave Roussy Cancer Campus,undefined

[5] Aix Marseille University,undefined

[6] APHM,undefined

[7] Metronomics Global Health Initiative,undefined

来源：

Cancer Chemotherapy and Pharmacology | 2022年 / 90卷

关键词：

Lung cancer; Mesothelioma; Mathematical modelling; Vinorelbine; Metronomic;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：149 / 160

页数：11

共 50 条

[21] Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial
Montagna, Emilia
Palazzo, Antonella
Maisonneuve, Patrick
Cancello, Giuseppe
Iorfida, Monica
Sciandivasci, Angela
Esposito, Angela
Cardillo, Anna
Mazza, Manuelita
Munzone, Elisabetta
Lai, Antonella
Goldhirsch, Aron
Colleoni, Marco
CANCER LETTERS, 2017, 400 : 276 - 281
[22] PHASE II TRIAL OF METRONOMIC ORAL VINORELBINE AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (MOVE TRIAL)
Camerini, A.
Puccetti, C.
Donati, S.
Valsuani, C.
Petrella, M. C.
Tartarelli, G.
Puccinelli, P.
Amoroso, D.
ANNALS OF ONCOLOGY, 2014, 25
[23] A phase II trial of low-dose metronomic oral vinorelbine as salvage treatment in advanced non-small cell lung cancer (NSCLC)
Agelaki, S.
Kontopodis, E. D.
Kentepozidis, N.
Giassas, S.
Vamvakas, L.
Androulakis, N.
Kotsakis, K.
Sfakiotaki, G.
Mavroudis, D.
Georgoulias, V
JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S448 - S448
[24] A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol
Xavier Elharrar
Dominique Barbolosi
Joseph Ciccolini
Christophe Meille
Christian Faivre
Bruno Lacarelle
Nicolas André
Fabrice Barlesi
BMC Cancer, 16
[25] A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic non-small cell lung cancer and malignant pleural mesothelioma: rationale and study protocol
Elharrar, Xavier
Barbolosi, Dominique
Ciccolini, Joseph
Meille, Christophe
Faivre, Christian
Lacarelle, Bruno
Andre, Nicolas
Barlesi, Fabrice
BMC CANCER, 2016, 16
[26] A phase I pharmacokinetic study of metronomic vinorelbine and sorafenib using two schedules in Asian non-small cell lung cancer (NSCLC) patients
Chen, S.
Sutiman, N.
Shih, V.
Tan, D.
Ang, M. K.
Toh, C. K.
Lim, D.
Ng, Q. S.
Tan, E. H.
Chowbay, B.
ANNALS OF ONCOLOGY, 2017, 28
[27] Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma
Miller, VA
Ng, KK
Krug, LM
Perez, W
Pizzo, B
Heelen, RT
Kris, MG
CANCER, 2000, 88 (05) : 1045 - 1050
[28] Metronomic oral vinorelbine as first-line treatment in elderly patients with advanced non-small cell lung cancer: results of a phase II trial (MOVE trial)
Andrea Camerini
Cheti Puccetti
Sara Donati
Chiara Valsuani
Maria Cristina Petrella
Gianna Tartarelli
Paolo Puccinelli
Domenico Amoroso
BMC Cancer, 15
[29] Phase I study of vinorelbine and paclitaxel in small-cell lung cancer
Rosario Vincenzo Iaffaioli
Gaetano Facchini
Anna Tortoriello
Francesco Caponigro
Alfonso Illiano
Maria Gentile
Adriano Gravina
Paolo Muto
Rosario Vincenzo Iaffaioli
Cancer Chemotherapy and Pharmacology, 1997, 41 : 86 - 90
[30] Phase I study of vinorelbine and paclitaxel in small-cell lung cancer
Iaffaioli, RV
Facchini, G
Tortoriello, A
Caponigro, F
Illiano, A
Gentile, M
Gravina, A
Muto, P
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1997, 41 (01) : 86 - 90

← 1 2 3 4 5 →